Although the upstream mechanisms mediating calcium signaling in CKD or following treatment with ESAs have not been elucidated, it is noteworthy that unselective calcium ion–permeable cation channels are inhibited by EPO which may thus counteract calcium entry [28]. This evidence concerns the gene EPO and chronic kidney disease.